RxDoctor Payments Data

John Thurman, DO

Family Medicine · Hutchinson, KSNPI 1619237849

Payments from drug & device makers

$373in general payments, 2019–2025

Across 23 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$77
  • Novo Nordisk$67
  • Amgen$56
  • AbbVie$32
  • Pfizer$29
  • Novartis$29
  • plus $83 from 6 others

What the payments were for

  • Food & beverage$373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$373 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$183,808
Medicare patients
543
Services billed
2,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$98,367
OzempicSemaglutide84$82,575
JardianceEmpagliflozin66$55,187
XareltoRivaroxaban24$19,269
Tresiba Flextouch U-100Insulin Degludec31$18,297
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog45$16,321
MounjaroTirzepatide13$15,951
SymbicortBudesonide/Formoterol Fumarate22$8,357
FarxigaDapagliflozin Propanediol14$8,044
LinzessLinaclotide14$7,377
Humalog Kwikpen U-100Insulin Lispro21$7,371
Arnuity ElliptaFluticasone Furoate22$6,171
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$5,265
LantusInsulin Glargine,hum.Rec.Anlog17$4,465
Novolin N FlexpenInsulin Nph Human Isophane14$4,433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$98,367128 claims
Novo NordiskOzempic$67$82,57584 claims
Boehringer IngelheimJardiance$11$55,18766 claims
Johnson & JohnsonXarelto$77$19,26924 claims
AstraZenecaSymbicort, Farxiga$13$16,40036 claims
AbbVieLinzess, Synthroid$32$8,91735 claims
GSKArnuity Ellipta$12$6,17122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Hutchinson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →